Betta Pharmaceuticals Co Ltd (300558) — Net Asset Momentum
Betta Pharmaceuticals Co Ltd (300558) recorded a net asset momentum of 17.7% as of December 2025, with net assets of CN¥6.67 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Betta Pharmaceuticals Co Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Betta Pharmaceuticals Co Ltd Net Asset Momentum (2011–2025)
This chart tracks Betta Pharmaceuticals Co Ltd's year-over-year net asset growth across 15 annual reporting periods from 2011 to 2025. The most recent momentum reading is +17.7%, with net assets of CN¥6.67 Billion CNY as of December 2025. Read Betta Pharmaceuticals Co Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Betta Pharmaceuticals Co Ltd (2011–2025)
The table below shows the complete annual net asset history for Betta Pharmaceuticals Co Ltd from 2011 to 2025, covering 15 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see 300558 market cap.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥6.67 Billion | CN¥10.57 Billion | CN¥3.90 Billion | ▲ +17.7% |
| 2024 | CN¥5.67 Billion | CN¥9.34 Billion | CN¥3.68 Billion | ▲ +5.9% |
| 2023 | CN¥5.35 Billion | CN¥9.15 Billion | CN¥3.80 Billion | ▲ +7.9% |
| 2022 | CN¥4.96 Billion | CN¥7.91 Billion | CN¥2.95 Billion | ▲ +5.8% |
| 2021 | CN¥4.69 Billion | CN¥6.27 Billion | CN¥1.59 Billion | ▲ +13.1% |
| 2020 | CN¥4.14 Billion | CN¥5.24 Billion | CN¥1.10 Billion | ▲ +67.8% |
| 2019 | CN¥2.47 Billion | CN¥4.13 Billion | CN¥1.66 Billion | ▲ +10.0% |
| 2018 | CN¥2.24 Billion | CN¥3.51 Billion | CN¥1.27 Billion | ▲ +8.6% |
| 2017 | CN¥2.07 Billion | CN¥2.77 Billion | CN¥706.48 Million | ▲ +7.1% |
| 2016 | CN¥1.93 Billion | CN¥2.17 Billion | CN¥238.27 Million | ▲ +115.8% |
| 2015 | CN¥893.95 Million | CN¥1.15 Billion | CN¥253.09 Million | ▲ +64.6% |
| 2014 | CN¥543.03 Million | CN¥662.93 Million | CN¥119.90 Million | ▲ +70.2% |
| 2013 | CN¥319.10 Million | CN¥410.81 Million | CN¥91.71 Million | ▲ +84.9% |
| 2012 | CN¥172.56 Million | CN¥261.00 Million | CN¥88.44 Million | ▲ +230.1% |
| 2011 | CN¥52.28 Million | CN¥215.11 Million | CN¥162.83 Million | — |